Ultrasound myocardial tissue characterization by integrated backscatter in children treated with anthracyclines

Pediatric Cardiology

Volumn 20, Issue 4, 1999, Pages 264-270

  Goens, M B ^a,b,c   Karr, S S ^a,b   Seibel, N ^a   Martin, G R ^a,b  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anthracycline; Cardiotoxicity; Echocardiography; Pediatric; Ultrasound tissue characterization

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; CARDIOTOXICITY; CHILD; CHILDHOOD CANCER; COMPUTER ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; FOLLOW UP; HEART CYCLE; HEART MUSCLE INJURY; HUMAN; IMAGE ANALYSIS; INFANT; MAJOR CLINICAL STUDY; NEWBORN; RADIATION SCATTERING;

ADOLESCENT; ADULT; ANTIBIOTICS, ANTINEOPLASTIC; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHOCARDIOGRAPHY; FEMALE; HEART; HUMANS; IMAGE ENHANCEMENT; INFANT; MALE; MYOCARDIUM; NEOPLASMS; PROSPECTIVE STUDIES; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0033003334     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002469900461     Document Type: Article

References (20)

1. Billingham ME, Masek MA (1993) The pathology of anthracycline cardiotoxicity in children, adolescents, and adults. In: Bricker JT, Green DM, D'Angio GJ (eds) Cardiac Toxicity after Treatment for Childhood Cancer. Wiley-Liss, New York, pp 17-24
2. Colan SD, Borow KM, Neumann A (1984) Left ventricular end-systolic wall stress-velocity of fiber shortening relation: a load-independent index of myocardial contractility. J Am Coll Cardiol 4:715-724
3. Colan SD, Parness IA, Spevak PJ, Sanders SP (1992) Developmental modulation of myocardial mechanics: age- and growth-related alterations in afterload and contractility. J Am Coll Cardiol 19:619-629
4. Goens MB, Karr SS, Martin GR (1996) Cyclic variation of integrated ultrasound backscatter: normal and abnormal myocardial patterns in children. J Am Soc Echocardiogr 9:616-621
5. Jakacki RI, Larsen RL, Barber G, et al. (1993) Comparison of cardiac function tests after anthracycline therapy in childhood. Implications for screening. Cancer 72:2739-2745
6. Karr SS, Martin GR (1994) A simplified method for calculating wall stress in infants and children. J Am Soc Echocardiogr 7:646-651
7. Lipshultz SE, Colan SD, Gelber RD, et al. (1991) Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 324:808-815
8. Lipshultz SE, Sanders SP, Goorin AM, et al. (1994) Monitoring for anthracycline cardiotoxicity. Pediatrics 93:433-437
9. Mimbs JW, O'Donnell M, Miller JG, Sobel BE (1981) Detection of cardiomyopathic changes induced by doxorubicin based on quantitative analysis of ultrasonic backscatter. Am J Cardiol 47: 1056-1060
10. Moreb JS, Oblon DJ (1992) Outcome of clinical congestive heart failure induced by anthracycline chemotherapy. Cancer 70:2637-2641
11. O'Brien PD, O'Brien WD, Rhyne TL, Warltier DC, Sagar KB (1995) Relation of ultrasonic backscatter and acoustic propagation properties to myofibrillar length and myocardial thickness. Circulation 91:171-175
12. O'Brien WD, Sagar KB, Warltier DC, Rhyne TL (1995) Acoustic propagation properties of normal, stunned, and infarcted myocardium: morphological and biochemical determinants. Circulation 91:154-160
13. Perez JE, McGill JB, Santiago JV, et al. (1992) Abnormal myocardial acoustic properties in diabetic patients and their correlation with the severity of disease. J Am Coll Cardiol 19:1154-1162
14. Perez JE, Miller JG, Holland MR, et al. (1994) Ultrasonic tissue characterization: integrated backscatter imaging for detecting myocardial structural properties and on-line quantitation of cardiac function. Am J Cardiac Imaging 8:106-112
15. Pihkala J, Sariola H, Saarinen UM (1994) Myocardial function and postmortem myocardial histology in children given anthracycline therapy for cancer. Pediatr Hematol Oncol 11:259-269
16. Rhoden W, Hasleton P, Brooks N (1993) Anthracyclines and the heart. Br Heart J 70:499-502
17. Sagar KB, Pelc LE, Rhyne TL, Wann S, Waltier DC (1988) Influence of heart rate, preload, afterload, and inotropic state on myocardial ultrasonic backscatter. Circulation 77:478-483
18. Steinherz LJ, Steinherz PG, Tan CTC, Heller G, Murphy ML (1991) Cardiac toxicity 4 to 20 years after completing anthracycline therapy. J Am Med Assoc 266:1672-1677
19. Steinherz LJ, Graham T, Hurwitz R, et al. (1992) Guidelines for cardiac monitoring children during and after anthracycline therapy: report of the cardiology committee of the Children's Cancer Study Group. Pediatrics 89:942-949
20. Von Hoff DD, Layard M, Basa P (1979) Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 91:710-717